ZNTL +15% on new CEO—and $230M* capital raise at a 6% discount to Friday’s closing price: https://finance.yahoo.com/news/zentalis-pharmaceuticals-appoints-oncology-clinical-110000046.html https://finance.yahoo.com/news/zentalis-pharmaceuticals-announces-pricing-underwritten-112800006.html *Assuming exercise of underwriter’s option.